Reset filter
Palabras clave
Treatment Form ×
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

722 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

CALGB: 90401 Medications Supplement Form NCT00110214

- 20/9/21 - 1 formulario, 4 itemgroups, 24 items, 1 idioma
Itemgroups: Header, Patient demographics, Cardiovascular pharmacotherapy evaluation, Comments
CALGB: 90401 Medications Supplement Form NCT00110214 Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=359FF873-CDE9-6CE9-E044-0003BA3F9857

1. Induction Acute Myeloid Leukemia <=60 years (AML2003) NCT00180102

- 20/9/21 - 1 formulario, 7 itemgroups, 37 items, 2 idiomas
Itemgroups: General Info, Daunorubicin, Ara-C, G-CSF, Cytopenia duration, Transfusions, Signature
AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years http://clinicaltrials.gov/show/NCT00180102 Prospektive, randomisierte, multizentrische Therapieoptimierungsstudie - Studienprotokoll AML2003

2. Induction AML-AZA elderly patients NCT00915252

- 20/9/21 - 1 formulario, 21 itemgroups, 88 items, 2 idiomas
Itemgroups: Patientendaten, Clinical finding, Differential blood count, Klinische Chemie, 5-Azacytidine, 5-Azacytidine - Dose no. 1, 5-Azacytidine - Dose no. 2, 5-Azacytidine - Dose no. 3, 5-Azacytidine - Dose no. 4, 5-Azacytidine - Dose no. 5, 5-Azacytidine dose reduction, Transfusions, Chemotherapy, Ara-C , Daunorubicin, G-CSF, Cytopenia duration, Leukopenia, Neutropenia, Thrombopenia, Unterschrift
2. Induktionstherapieblock EudraCT-Nr 2008-004583-40 Akute myeloische Leukmie(AML) AML alle auer FAB M3 (5-Azacytidin plus Standardtherapie bei älteren AML-Patienten Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (AML-AZA) NCT00915252

North Central Cancer Treatment Group Evaluation/Observation Form NCT00377156

- 20/9/21 - 1 formulario, 8 itemgroups, 29 items, 1 idioma
Itemgroups: Header, Patient status assessment, Neurologic Examination, Observation, Systemic Disease Follow-up Status, Notice of First Recurrence, Treatment of Any Recurrence, Notice of New Primary
North Central Cancer Treatment Group Evaluation/Observation Form NCT00377156 Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=109FB871-880B-538E-E044-0003BA3F9857

Breast Cancer NCT00433511 Treatment - E5103 Radiation Therapy Form - 2543728v1.0 - E5103 Radiation Therapy Form

- 20/9/21 - 1 formulario, 5 itemgroups, 40 items, 1 idioma
Itemgroups: Header1, Header2, Header, Whole Breast Irradiation, Partial Breast Irradiation
E5103 Radiation Therapy Form Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=22AFD24B-EC68-5512-E044-0003BA3F9857

Leukemia NCT01041703 Treatment - E2906 Allogeneic Transplant Form - Arm G - 2951703v1.0 - E2906 Allogeneic Transplant Form - Arm G

- 20/9/21 - 1 formulario, 9 itemgroups, 43 items, 1 idioma
Itemgroups: Header Module, Reporting Period, Header, Vital Status, Preparative Conditioning Regimen, Preparative Conditioning Regimen1, Donor Information, Allogeneic Transplant, Footer Module
E2906 Allogeneic Transplant Form - Arm G Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=758373C9-BE14-F79E-E040-BB89AD433D62

Treatment Form Breast Cancer Early Stage NCIC MA.32 NCT01101438

- 20/9/21 - 1 formulario, 26 itemgroups, 115 items, 1 idioma
Itemgroups: Patient Information, TIMING OF REPORT, PHYSICAL EXAM - ON TREATMENT, DISEASE STATUS, IN SITU DISEASE FOLLOW-UP, KIT RETURN - QUESTION, KIT RETURN, KIT DISPENSION - QUESTION, KIT DISPENSATION, METFORMIN/PLACEBO ADMINISTRATION - RAMP-UP, METFORMIN/PLACEBO ADMINISTRATION, RADIOLOGY INVESTIGATIONS - QUESTION, RADIOLOGY INVESTIGATIONS, HEMATOLOGY , BIOCHEMISTRY, SERIOUS ADVERSE EVENT - QUESTION, ADVERSE EVENTS ON TREATMENT - QUESTION, ADVERSE EVENTS, CARDIOVASCULAR MORBIDITY - QUESTION, CARDIOVASCULAR MOBIDITY, CANCER TREATMENT SINCE LAST REPORT ¿ QUESTION, CANCER TREATMENT SINCE LAST REPORT, MAJOR MEDICAL PROBLEMS, QUESTIONNAIRES, Comments, Contact Information
NCIC MA.32 Treatment Report Form A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=80FC65BF-C111-5459-E040-BB89AD430BEC

consolidation therapy 2 AML in elderly patients AML-AZA NCT00915252

- 20/9/21 - 1 formulario, 21 itemgroups, 85 items, 2 idiomas
Itemgroups: Patientendaten, Clinical finding, Differentialblutbild, Clinical Chemistry, 5-Azacytidine, 5-Azacytidine , 5-Azacytidine - Dose no. 1, 5-Azacytidine - Dose no. 2, 5-Azacytidine - Dose no. 3, 5-Azacytidine - Dose no. 4, 5-Azacytidine - Dose no. 5, 5-Azacytidine dose reduction, Transfusions, Chemotherapy, Ara-C, G-CSF, Cytopenia duration, leukopenia, neutropenia, thrombopenia, Unterschrift
2. Konsolidierungstherapieblock EudraCT-Nr 2008-004583-40 Akute myeloische Leukämie(AML) AML alle außer FAB M3 consolidation therapy 2 AML in elderly patients AML-AZA NCT00915252 A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML

Breast Cancer DataMart Common Data Elements for Adjuvant Clinical Trials

- 20/9/21 - 1 formulario, 16 itemgroups, 122 items, 1 idioma
Itemgroups: Patient Characteristics, Patient Performance Status, Protocol Design, Surgical Procedures, Pathologic Disease Classification, Pathology: Assessment of Lymph Nodes, Margins, Estrogen Status, Progesterone Status, Pathology: Breast Tumor Markers, Pathology: Assessment of Ductal Carcinoma In Situ (DCIS), Pathology: Assessment of Lobular Carcinoma In Situ (LCIS), Endpoints, Tumor Response, Sites of Progression, Notice of New Primary
Treatment - Breast Cancer DataMart Common Data Elements for Adjuvant Clinical Trials - 2719861v1.0 Breast Cancer DataMart Common Data Elements for Adjuvant Clinical Trials Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=43B3F0AE-1119-0B42-E044-0003BA3F9857

NCT00980954 RTOG 0724 Phase III Cervix Chemo RT (+)/(-) Adjuvant Chemotherapy: Concurrent Systemic Treatment Summary Form (TF)

- 20/9/21 - 1 formulario, 6 itemgroups, 59 items, 1 idioma
Itemgroups: RTOG clinical trial administrative data, Summary of Systemic Treatment, Treatment Summary, Protocol Specific Adverse Event Evaluation, Lab results, Footer Module
NCT00980954 RTOG 0724 Phase III Cervix Chemo RT (+)/(-) Adjuvant Chemotherapy: Concurrent Systemic Treatment Summary Form (TF) Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5FE95381-CD25-390D-E040-BB89AD436907

NCT00980954 RTOG 0724 Phase III Cervix Chemo RT (+)/(-) Adjuvant Chemotherapy: Adjuvant System Treatment Summary Form (SF)

- 20/9/21 - 1 formulario, 6 itemgroups, 61 items, 1 idioma
Itemgroups: RTOG clinical trial administrative data, Summary of Systemic Treatment, Treatment Summary, Adverse Events, Lab results, Comments
NCT00980954 RTOG 0724 Phase III Cervix Chemo RT (+)/(-) Adjuvant Chemotherapy: Adjuvant System Treatment Summary Form (SF) Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5CFDEE98-0544-2FA7-E044-0003BA3F9857

Radiation Therapy Oncology Group Initial Follow-up Form Phase III Lung Prophylactic Cranial RT NCT00048997

- 20/9/21 - 1 formulario, 3 itemgroups, 46 items, 1 idioma
Itemgroups: Header Module, Medical history, Comments
Radiation Therapy Oncology Group Initial Follow-up Form Phase III Lung Prophylactic Cranial RT Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer NCT00048997 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9EC372A6-7094-05D5-E034-080020C9C0E0

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial